Bloomberg: The Way Ahead

Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...

READ MORE

All Hands on Deck for Fill/Finish of Vaccines and Therapeutics

“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...

READ MORE

Preparing Pandemic Vaccine Capacity

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently contributed to an editorial in ...

READ MORE

COVID-19: 'Pandemic-ready' set-up placing Emergent apart in CDMO Space

In a recent article with BioProcess International, Syed T. Husain, senior vice president & CDMO business unit head at Emergent...

READ MORE

EMERGENT IN THE NEWS: COVID-19 General Coverage

Read the latest news coverage of Emergent's insights and involvement in the fight against COVID-19. Last Updated: Thursday,...

READ MORE

Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate

  • Emergent will provide contract development and manufacturing services beginning in 2021 to produce drug substance at large...
READ MORE
WANT MORE INFORMATION?

Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at cdmo@ebsi.com.

Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.

WANT MORE INFORMATION?

Learn more about Emergent CDMO’s work and the many milestones we’ve reached in our news release archive below.  If you’re a media representative, please feel free to contact us at mediarelations@ebsi.com.

Interested in learning more about Emergent BioSolutions, Inc.? Please visit emergentbiosolutions.com.